Responses

Download PDFPDF

Should children with Henoch-Schonlein purpura and abdominal pain be treated with steroids?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Should children with Henoch-Schonlein purpura and abdominal pain be treated with steroids?
    • Jae Seung Lee, Pediatric Nephrologist, Professor
    • Other Contributors:
      • Jae Il Shin

    Dear Editor,

    We read with interest an article on “Should children with Henoch- Schonlein purpura and abdominal pain be treated with steroids?” by Haroon et al.[1] Considering the low incidence of Henoch-Schonlein purpura (HSP) in children (20.4 per 100 000 children in the United Kingdom, and 12.9 per 100 000 children in Taiwan),[2, 3] a randomised controlled trial in a large cohort would be difficult to conduct. Har...

    Show More
    Conflict of Interest:
    None declared.